Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.
Open Access
- 1 March 1995
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (3), 1124-1132
- https://doi.org/10.1172/jci117760
Abstract
These studies were undertaken to quantify cholesterol balance across the plasma space and the individual organs of the mouse, and to determine the role of the low density lipoprotein receptor (LDLR) in these two processes. In the normal mouse (129 Sv), sterol was synthesized at the rate of 153 mg/d per kg body weight of which 78% occurred in the extrahepatic tissues while only 22% took place in the liver. These animals metabolized 7.1 pools of LDL-cholesterol (LDL-C) per day, and 79% of this degradation took place in the liver. Of this total turnover, the LDLR accounted for 88% while the remaining 12% was receptor independent. 91% of the receptor-dependent transport identified in these animals was located in the liver while only 38% of the receptor-independent uptake wsa found in this organ. When the LDLR was deleted, the LDL-C production rate increased 1.7-fold, LDL-C turnover decreased from 7.1 to 0.88 pools/d, and the plasma LDL-C level increased 14-fold, from 7 to 101 mg/dl. Despite these major changes in the circulating levels of LDL-C, however, there was no change in the rate of cholesterol synthesis in any extrahepatic organ or in the whole animal, and, further, there was no change in the steady-state cholesterol concentration in any organ. Thus, most extrahepatic tissues synthesize their daily sterol requirements while most LDL-C is returned directly to the liver. Changes in LDLR activity, therefore, profoundly alter the plasma LDL-C concentration but have virtually no affect on cholesterol balance across any extrahepatic organ, including the brain.This publication has 52 references indexed in Scilit:
- Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liverGastroenterology, 1994
- High prevalence of familial defective apolipoprotein B-100 in Switzerland.Journal of Lipid Research, 1994
- Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humansJournal of Lipid Research, 1993
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Developmental and age-related changes in apolipoprotein B mRNA editing in mice.Journal of Lipid Research, 1992
- Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.Journal of Biological Chemistry, 1992
- Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools.Proceedings of the National Academy of Sciences, 1992
- Inhibition of receptor-mediated clearance of lysine and arginine modified lipoproteins from the plasma of rats and monkeysProceedings of the National Academy of Sciences, 1980
- Metabolic Studies in Familial HypercholesterolemiaJournal of Clinical Investigation, 1979
- Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.Journal of Biological Chemistry, 1978